We all knew this was going to happen.
Nanotechnology has become the neglected stepchild of the markets. The hype and fervor surrounding it a few years ago gave way to warnings that the science would yield precious few applications — and profit — for years.
Then came disappointment and then, in the minds of investors at least, oblivion.
Aside from some erratic stocks, like Altair Nanotechnologies (ALTI - Cramer’s Take - Stockpickr - Rating) [profile], whose shares are volatile as a result of perennial speculation, and the even-rarer company turning a profit, like electron-microscope maker FEI (FEIC - Cramer’s Take - Stockpickr - Rating) [profile], companies toiling in science on the nanoscale have been quietly treading water.
A nanotech exchange-traded fund representing an index of stocks that was set up by Lux Research
